All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

It is increasingly recognised that infections often involve multiple pathogen species or strains/clones of the same species \[[@pbio.3000551.ref001], [@pbio.3000551.ref002]\]. Infection by one pathogen can affect susceptibility to subsequent infection by others \[[@pbio.3000551.ref003], [@pbio.3000551.ref004]\]. Coinfection can also affect the severity and/or duration of infection, as well as the extent of symptoms and the level of infectiousness \[[@pbio.3000551.ref005]\]. Antagonistic, neutral, and facilitative interactions are possible \[[@pbio.3000551.ref006], [@pbio.3000551.ref007]\]. Coinfection therefore potentially has significant epidemiological, clinical, and evolutionary implications \[[@pbio.3000551.ref008]--[@pbio.3000551.ref010]\].

However, detecting and quantifying biological interactions between pathogens is notoriously challenging \[[@pbio.3000551.ref011], [@pbio.3000551.ref012]\]. In pathogens of some host taxa, most notably plant pathogens, biological interactions can be quantified by direct experimentation \[[@pbio.3000551.ref013]\]. However, often ethical considerations mean this is impossible, and so any signal of interaction must be extracted from population-scale data. Analysis of longitudinal data remains the gold standard \[[@pbio.3000551.ref014]\], although the associated methods are not infallible \[[@pbio.3000551.ref015]\]. However, collecting longitudinal data requires a dedicated and intensive sampling campaign, meaning in practice cross-sectional data are often all that are available. Methods for cross-sectional data typically concentrate on identifying deviation from statistical independence, using standard methods such as *χ*^2^ tests or log-linear modelling to test whether the observed probability of coinfection differs from the product of the prevalences of the individual pathogens \[[@pbio.3000551.ref016]--[@pbio.3000551.ref026]\]. Detecting such a nonrandom statistical association between pathogens is then taken to signal a biological interaction. The underlying mechanism can range, for example, from individual-scale direct effects on within-host pathogen dynamics \[[@pbio.3000551.ref013], [@pbio.3000551.ref027]\], to indirect within-host immune-mediated interactions \[[@pbio.3000551.ref028]\], to indirect population-scale 'ecological interference' caused by competition for susceptible hosts \[[@pbio.3000551.ref029], [@pbio.3000551.ref030]\].

A well-known difficulty is that factors other than biological interactions between pathogens can drive statistical associations. For instance, host heterogeneity---that some hosts are simply more likely than others to become infected---can generate positive statistical associations, since coinfection is more common in the most vulnerable hosts. Heterogeneity in host age can also generate statistical associations, as infections accumulate in older individuals \[[@pbio.3000551.ref031]--[@pbio.3000551.ref033]\]. Methods aimed at disentangling such confounding factors have been developed but show mixed results in detecting biological interactions \[[@pbio.3000551.ref034]--[@pbio.3000551.ref037]\]. Methods using dynamic epidemiological models to track coinfections are also emerging, although more often than not requiring longitudinal data \[[@pbio.3000551.ref038]--[@pbio.3000551.ref042]\].

More fundamentally, however, the underpinning and long-standing assumption that noninteraction implies statistical independence \[[@pbio.3000551.ref043], [@pbio.3000551.ref044]\] has not been challenged. Here, we confront the intuition that biological interactions can be detected via statistical associations, demonstrating how simple epidemiological models can change the way we think about biological interactions. In particular, we show that noninteracting pathogens should not be expected to have prevalences that are statistically independent. Coinfection by noninteracting pathogens is more probable than multiplication would suggest, invalidating any test invoking statistical independence.

The paper is organised as follows. First, we use a simple epidemiological model to show that the probability that a host is coinfected by both of a pair of noninteracting pathogens is greater than the product of the net prevalences of the individual pathogens. Second, we extend this result to an arbitrary number of noninteracting pathogens. This allows us to construct a novel test for biological interaction, based on testing the extent to which coinfection data can be explained by our epidemiological models in which pathogens do not interact. Different versions of this test, conditioned on the form of available data and whether coinfections are caused by different pathogen species, allow us to reinterpret a number of previous reports \[[@pbio.3000551.ref017], [@pbio.3000551.ref022], [@pbio.3000551.ref045]--[@pbio.3000551.ref051]\]. Our examples include plant, animal, and human pathogens, and the methodology can potentially be applied to any cross-sectional survey data tracking coinfection.

Results {#sec002}
=======

Two noninteracting pathogens {#sec003}
----------------------------

### Dynamics of the individual pathogens {#sec004}

We consider two distinct pathogen species, strains, or clones (henceforth 'pathogens'), which we assume do not interact; i.e., the interaction between the host and one of the pathogens is entirely unaffected by its infection status with respect to the other. Epidemiological properties that are therefore unaffected by the presence or absence of the other pathogen include initial susceptibility; within-host dynamics, including rates of accumulation and/or movement within tissues; host responses to infection; and onward transmission. Assuming a fixed-size host population and susceptible-infected-susceptible (S-I-S) dynamics \[[@pbio.3000551.ref052]\], the proportion of the host population infected by pathogen *i*∈{1,2} follows $${\overset{˙}{I}}_{i} = \beta_{i}I_{i}(1 - I_{i}) - \mu I_{i},$$ in which the dot denotes differentiation with respect to time, *β*~*i*~ is a pathogen-specific infection rate, and *μ* is the host\'s natural death rate.

Whereas natural mortality may be negligible for acute infections, it cannot be neglected for chronic (i.e., long-lasting) infections, which are responsible for a large fraction of coinfections in humans and animals \[[@pbio.3000551.ref003], [@pbio.3000551.ref053]\]. Likewise, plants remain infected over their entire lifetime following infection by most pathogens, including almost all plant viruses, as well as the anther smut fungus, which drives one of our examples here \[[@pbio.3000551.ref045]\].

We assume that the disease-induced death rate (virulence) is zero, as otherwise there would be ecological interactions between pathogens \[[@pbio.3000551.ref030]\]. However, our model can be extended to handle pathogen-specific rates of clearance ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 4; [S2 Text](#pbio.3000551.s002){ref-type="supplementary-material"}, Section 3).

### Tracking coinfection {#sec005}

Making identical assumptions, but instead distinguishing hosts infected by different combinations of pathogens, leads to an alternate representation of the dynamics. We denote the proportion of hosts infected by only one of the two pathogens by *J*~*i*~, with *J*~1,2~ representing the proportion coinfected. Pathogen-specific net forces of infection are $$F_{i} = \beta_{i}I_{i} = \beta_{i}(J_{i} + J_{1,2}),$$ and so $$\begin{matrix}
{{\overset{˙}{J}}_{1} = F_{1}J_{\varnothing} - (F_{2} + \mu)J_{1},} \\
{{\overset{˙}{J}}_{2} = F_{2}J_{\varnothing} - (F_{1} + \mu)J_{2},} \\
{{\overset{˙}{J}}_{1,2} = F_{2}J_{1} + F_{1}J_{2} - \mu J_{1,2},} \\
\end{matrix}$$ in which *J*~∅~ = 1−*J*~1~−*J*~2~−*J*~1,2~ is the proportion of hosts uninfected by either pathogen ([Fig 1](#pbio.3000551.g001){ref-type="fig"}).

![Schematic of the model tracking a pair of noninteracting pathogens.\
The model is defined in Eqs [1](#pbio.3000551.e001){ref-type="disp-formula"}--[3](#pbio.3000551.e003){ref-type="disp-formula"}: *J*~∅~ denotes uninfected hosts; *J*~1~ and *J*~2~ are hosts singly infected by pathogens 1 and 2, respectively; *J*~1,2~ are coinfected hosts; *I*~1~ = *J*~1~+*J*~1,2~ and *I*~2~ = *J*~2~+*J*~1,2~ are net densities of hosts infected by pathogens 1 and 2, respectively.](pbio.3000551.g001){#pbio.3000551.g001}

### Prevalence of coinfected hosts {#sec006}

We assume the basic reproduction number, *R*~0,*i*~ = *β*~*i*~/*μ*\>1, for both pathogens. Solving [Eq 3](#pbio.3000551.e003){ref-type="disp-formula"} numerically for arbitrary but representative parameters ([Fig 2A](#pbio.3000551.g002){ref-type="fig"}) shows the proportion of coinfected hosts (*J*~1,2~) to be larger than the product of the individual prevalences (*P* = *I*~1~*I*~2~ from [Eq 1](#pbio.3000551.e001){ref-type="disp-formula"}). That *J*~1,2~(*t*)≥*P*(*t*) for large *t* (for all parameters) can be proved analytically ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 1.1). Numerical exploration of the model suggests that *J*~1,2~(*t*) invariably becomes larger than *P*(*t*) relatively rapidly, and well within the lifetime of an average host, over a wide range of initial conditions and plausible sets of parameter values ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 1.2; [S1 Fig](#pbio.3000551.s003){ref-type="supplementary-material"}).

![Simulations of the two-pathogen model show that net densities of the two pathogens are positively correlated.\
*J*~1~. and *J*~2~ are hosts singly infected by pathogens 1 and 2, respectively; *J*~1,2~ is coinfected hosts; *I*~1~=*J*~1~+*J*~1,2~ and *I*~2~=*J*~2~+*J*~1,2~ are net densities of hosts infected by pathogens 1 and 2, respectively. (A) Dynamics of the deterministic model (Eqs [1](#pbio.3000551.e001){ref-type="disp-formula"}--[3](#pbio.3000551.e003){ref-type="disp-formula"}), with *β*~1~ = 5, *β*~2~ = 2.5, and *μ* = 1 (parameters have units of inverse time). (B) Dynamics of a stochastic version of the model, in a population of size *N* = 1,000 (see also [Methods](#sec012){ref-type="sec"} section 'Stochastic models'). (C) A single trajectory from the stochastic simulation (black line) in panel B (restricted to the time interval starting from the dashed line at *t* = 5) in the phase plane (*I*~1~,*I*~2~), and the 90% and 99% confidence ellipses (dashed and dotted curves, respectively) generated from an analytical approximation to the stochastic model. The grey dots represent pairs of individual values of (*I*~1~,*I*~2~) sampled at time *T* = 10 from 10^3^ independent replicates of the stochastic model. (D) The probability density of Λ, the relative deviation of the prevalence of coinfection ([Eq 5](#pbio.3000551.e007){ref-type="disp-formula"}), as estimated at *T* = 10 from 10^4^ independent replicates of our stochastic model when *N* = 1,000. The relative deviation was much greater than zero in all individual simulations. The mean value of Λ as estimated from these simulations, $\overline{\Lambda} \approx 0.1542$, was extremely close to the prediction from the deterministic model, Λ = 1/(5+2.5−1)≈0.1538 ([Eq 5](#pbio.3000551.e007){ref-type="disp-formula"}; these values are marked by red open and blue filled dots on the x-axis).](pbio.3000551.g002){#pbio.3000551.g002}

Simulations of a stochastic analogue of the model ([Fig 2B](#pbio.3000551.g002){ref-type="fig"}) reveal the key driver of this behaviour. The net prevalences of the pathogens considered in isolation, *I*~1~ and *I*~2~, are positively correlated ([Fig 2C](#pbio.3000551.g002){ref-type="fig"}; [Eq 27](#pbio.3000551.e050){ref-type="disp-formula"} in Methods section 'Stochastic models'), because of simultaneous reductions whenever coinfected hosts die. The full distribution of point estimates of the relative deviation from statistical independence (see [Eq 5](#pbio.3000551.e007){ref-type="disp-formula"}) indicates the deviation is reliably greater than zero across an ensemble of runs of our stochastic model ([Fig 2D](#pbio.3000551.g002){ref-type="fig"}). That the deviation is routinely positive is robust to alternative formulations of the stochastic model including environmental as well as demographic noise ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 6.1; [S2 Fig](#pbio.3000551.s004){ref-type="supplementary-material"}). It also becomes apparent quickly across a wide range of initial conditions; i.e., the sign and magnitude of the relative deviation are relatively robust to transient behaviour of our model ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 6.2; [S3 Fig](#pbio.3000551.s005){ref-type="supplementary-material"}).

### Quantifying the deviation from statistical independence {#sec007}

For *R*~0,*i*~\>1, the equilibrium prevalence of coinfection in our deterministic model is given by $${\overline{J}}_{1,2} = \left( \frac{\beta_{1} + \beta_{2}}{\beta_{1} + \beta_{2} - \mu} \right){\overline{I}}_{1}{\overline{I}}_{2}.$$

(See also [Methods](#sec012){ref-type="sec"} section 'Equilibria of the two-pathogen model'). We introduce Λ, the relative deviation of the prevalence of coinfection from that required by statistical independence ($\overline{P} = {\overline{I}}_{1}{\overline{I}}_{2}$), which here is given by $$\Lambda = \frac{{\overline{J}}_{1,2} - \overline{P}}{\overline{P}} = \frac{\mu}{\beta_{1} + \beta_{2} - \mu} = \frac{1}{R_{0,1} + R_{0,2} - 1} \geq 0.$$

The deviation is zero if, and only if, the host natural death rate is *μ* = 0. The observed outcome would therefore conform with statistical independence only for noninteracting pathogens when there is no host natural death (at the time scale of an infection). This reiterates the role of host natural death in causing deviation from a statistical association pattern. The relative deviation from statistical independence, Λ, becomes smaller as either or both values of *R*~0,*i*~ become larger. Deviations are therefore more apparent for smaller values of *R*~0,*i*~. This is unsurprising, since if either pathogen has a very large value of *R*~0~, almost all hosts infected with the other pathogen would be expected to become coinfected, and so both our model and the assumption of statistical independence would lead to very similar predictions.

This result ([Eq 5](#pbio.3000551.e007){ref-type="disp-formula"}) was first published by Kucharski and Gog \[[@pbio.3000551.ref032]\] in a different context (model reduction in multistrain influenza models). Moreover, using a continuous age-structured model, these authors showed that one may recover statistical independence within infinitesimal age classes. The result in [Eq 5](#pbio.3000551.e007){ref-type="disp-formula"} is related to ageing, as individuals acquire more infections as they age. As age increases, so does the probability of being infected with pathogens 1 and/or 2. Therefore, the prevalences of pathogens 1 and 2 are positively correlated \[[@pbio.3000551.ref033]\]. A greater deviation from independence as the mortality rate *μ* increases is likely due to the fact that prevalence is increasing and concave with respect to age and saturates in older age classes \[[@pbio.3000551.ref031]\].

Testing for interactions between pathogens {#sec008}
------------------------------------------

[Eq 3](#pbio.3000551.e003){ref-type="disp-formula"} can be straightforwardly extended to track *n* pathogens that do not interact in any way (including pairwise and three-way interactions). Equilibria of this model are prevalences of different classes of infected or coinfected hosts carrying different combinations of noninteracting pathogens. These can be used to derive a test for interaction between pathogens that properly accounts for the lack of statistical independence revealed by our analysis of the simple two-pathogen model.

### Modelling coinfection by *n* noninteracting pathogens {#sec009}

We denote the proportion of hosts simultaneously coinfected by the (nonempty) set of pathogens Γ to be *J*~Γ~ and use Ω~*i*~ = Γ\\{*i*} (for *i*∈Γ) to represent combinations with one fewer pathogen.

The dynamics of the 2^*n*^−1 distinct values of *J*~Γ~ follow $${\overset{˙}{J}}_{\Gamma} = \sum\limits_{i \in \Gamma}F_{i}J_{\Omega_{i}} - \left( {\sum\limits_{i \notin \Gamma}F_{i} + \mu} \right)J_{\Gamma},$$ in which the net force of infection of pathogen *i* is $$F_{i} = \beta_{i}I_{i} = \beta_{i}\sum\limits_{\Gamma \in \nabla_{i}}J_{\Gamma},$$ and ∇~*i*~ is the set of all subsets of {1,...,*n*} containing *i* as an element. [Eq 6](#pbio.3000551.e008){ref-type="disp-formula"} can be interpreted by noting the following:

-   the first term tracks inflow due to hosts carrying one fewer pathogen becoming infected;

-   the second term tracks the outflows due to hosts becoming infected by an additional pathogen, or death.

If *R*~0,*i*~ = *β*~*i*~/*μ*\>1 for all *i* = 1,...,*n*, the equilibrium prevalence of hosts predicted to be infected by any given combination of pathogens, ${\overline{J}}_{\Gamma}$, can be obtained by (recursively) solving a system of 2^*n*^ linear equations ([Eq 16](#pbio.3000551.e028){ref-type="disp-formula"} in Methods section 'Equilibria of the *n*-pathogen model').

These equilibrium prevalences are the prediction of our 'Noninteracting Distinct Pathogens' (NiDP) model, which in dimensionless form has *n* parameters (the *R*~0,*i*~\'s, *i* = 1,...,*n*; Methods section 'Fitting the models').

If we simplify the model by assuming that all pathogens are epidemiologically interchangeable and so all pathogen infection rates are equal (i.e., *β*~*i*~ = *β* for all *i*), then if *R*~0~ = *β*/*μ*\>1, the proportion of hosts infected by *k* distinct pathogens can be obtained by (recursively) solving *n*+1 linear equations ([Eq 22](#pbio.3000551.e041){ref-type="disp-formula"} in Methods section 'Deriving the NiSP model from the NiDP model'). This constitutes the prediction of our 'Noninteracting Similar Pathogens' (NiSP) model, a simplified form of the NiDP model requiring only a single parameter (*R*~0~).

### Using the models to test for interactions {#sec010}

If either the NiSP or NiDP model adequately explains coinfection data, those data are consistent with the underpinning assumption that pathogens do not interact. Which model is fitted depends on the form of the available data, specifically whether only the number of pathogens or instead which particular combination of pathogens infecting each host is known.

Studies often quantify only the number of distinct pathogens carried by individual hosts, without necessarily specifying the combinations involved \[[@pbio.3000551.ref022], [@pbio.3000551.ref045]--[@pbio.3000551.ref050]\]. There are insufficient degrees of freedom in such data to fit the NiDP model, and so we fall back upon the NiSP model. In using the NiSP model, we additionally assume all pathogens within a given study are epidemiologically interchangeable.

We identified four suitable studies reporting data concerning strains/clones of a single pathogen and tested whether these data are consistent with no interaction. For all four studies ([Fig 3](#pbio.3000551.g003){ref-type="fig"}), the best-fitting NiSP model is a better fit to the data than the corresponding binomial model assuming statistical independence ([Eq 28](#pbio.3000551.e051){ref-type="disp-formula"} in Methods section 'Models corresponding to assuming statistical independence'). Application of our model to three additional examples for data sets considering distinct pathogens, which deviate more markedly from the epidemiological equivalence assumption, is described in [S2 Text](#pbio.3000551.s002){ref-type="supplementary-material"}, Section 1 (see also [S4 Fig](#pbio.3000551.s006){ref-type="supplementary-material"}, [S1 Table](#pbio.3000551.s008){ref-type="supplementary-material"}, [S2 Table](#pbio.3000551.s009){ref-type="supplementary-material"}).

![Comparing predictions of the NiSP model with binomial models assuming statistical independence.\
In using the NiSP model, pathogens are assumed to be epidemiologically interchangeable: we have therefore restricted attention to data sets concerning strains/clones of a single pathogen species. (A) Strains of human papillomavirus \[[@pbio.3000551.ref022]\]; (B) strains of the anther smut pathogen (*Microbotryum violaceum*) on the white campion (*Silene latifolia*) \[[@pbio.3000551.ref045]\]; (C) strains of tick-transmitted bacteria (*Borrelia afzelii*) on bank voles (*Myodes glareolus*) \[[@pbio.3000551.ref046]\]; and (D) clones of malaria (*Plasmodium vivax*) \[[@pbio.3000551.ref047]\]. Insets to each panel show a 'zoomed-in' section of the graph corresponding to high multiplicities of clone/strain coinfection, using a logarithmic scale on the y-axis for clarity. Asterisks indicate predicted counts smaller than 0.1. In all four cases, the NiSP model is a better fit to the data than the binomial model (Δ AIC = 572.8,158.6,293.8 and 596.3, respectively). For the data shown in (A), there is no evidence that the NiSP model does not fit the data (lack of goodness of fit *p* = 0.08), and so our test indicates the human papillomavirus strains do not interact. For the data shown in (B--D), there is evidence of lack of goodness of fit (all have lack of goodness of fit *p*\<0.01). Our test therefore indicates these strains/clones interact (or are epidemiologically different). The underlying data for this figure can be found in [S3 Data](#pbio.3000551.s014){ref-type="supplementary-material"}, [S4 Data](#pbio.3000551.s015){ref-type="supplementary-material"}, [S5 Data](#pbio.3000551.s016){ref-type="supplementary-material"}, and [S6 Data](#pbio.3000551.s017){ref-type="supplementary-material"}. AIC, Akaike information criterion; NiSP, Noninteracting Similar Pathogens.](pbio.3000551.g003){#pbio.3000551.g003}

In one case---coinfection by different strains of human papillomavirus (HPV) \[[@pbio.3000551.ref022]\] ([Fig 3A](#pbio.3000551.g003){ref-type="fig"})---we find no evidence that the reported data cannot be explained by the NiSP model. These data therefore support the hypothesis of no interaction---and indeed no epidemiological differences---between the pathogen strains in question.

In the three other cases we considered---strains of anther smut (*M*. *violaceum*) on the white campion (*S*. *latifolia*) \[[@pbio.3000551.ref045]\] ([Fig 3B](#pbio.3000551.g003){ref-type="fig"}), strains of the tick-transmitted bacterium *B*. *afzelii* on bank voles (*M*. *glareolus*) \[[@pbio.3000551.ref046]\] ([Fig 3C](#pbio.3000551.g003){ref-type="fig"}), and clones of a single malaria parasite (*P*. *vivax*) infecting children \[[@pbio.3000551.ref047]\] ([Fig 3D](#pbio.3000551.g003){ref-type="fig"})---despite outperforming the model corresponding to statistical independence, the best-fitting NiSP model does not adequately explain the data. We therefore reject the hypotheses of no interaction in all three cases, noting that our use of the NiSP model means it might be epidemiological differences between pathogen strains/clones---or perhaps simply lack of fit of the underpinning S-I-S model---that have in fact been revealed.

Other studies report the proportion of hosts infected by particular combinations (rather than counts) of pathogens, although many of those concentrate on helminth macroparasites for which our underlying S-I-S model is well known to be inappropriate \[[@pbio.3000551.ref054]\].

However, a methodological article by Howard and colleagues \[[@pbio.3000551.ref017]\] introduces the use of log-linear modelling to test for statistical associations. Conveniently, that article reports the results of that methodology as applied to a large number of studies focusing on *Plasmodium* spp. causing malaria.

By interrogating the original data sources (Methods section 'Combinations of pathogens \[NiDP model\]'), we found a total of 41 studies of malaria reporting the disease status of at least *N* = 100 individuals, and in which three of *P*. *falciparum*, *P*. *malariae*, *P*. *ovale*, and *P*. *vivax* were considered. Data therefore consist of counts of the number of individuals infected with different combinations of three of these four pathogens, a total of eight classes. There were sufficient degrees of freedom to fit the NiDP model, which here has three parameters, each corresponding to the infection rate of a single *Plasmodium* spp. [Fig 4A](#pbio.3000551.g004){ref-type="fig"} shows the example of fitting the NiDP model to data from a study of malaria in Nigeria \[[@pbio.3000551.ref051]\].

![Using the NiDP model to reanalyse malaria data sets considered by Howard and colleagues \[[@pbio.3000551.ref017]\].\
In using the NiDP model, there is no need to assume malaria-causing *Plasmodium* spp. are epidemiologically interchangeable. (A) Comparing the predictions of the NiDP model with a multinomial model of infection (i.e., statistical independence) for the data set on *P*. *falciparum* ('F'), *P*. *malariae* ('M'), and *P*. *ovale* ('O') coinfection in Nigeria reported by Molineaux and colleagues \[[@pbio.3000551.ref051]\]. The NiDP model is a better fit to the data than the multinomial model (Δ AIC = 326.2); additionally, there is no evidence of lack of goodness of fit (*p* = 0.40). This data set is therefore consistent with no interaction between the three *Plasmodium* species. (B) Comparing the results of fitting the NiDP model and the methodology of Howard and colleagues \[[@pbio.3000551.ref017]\] based on log-linear regression and so statistical independence. For 16 (i.e., 12 + 4) out of the 41 data sets we considered, the conclusions of the two methods differ. The underlying data for this figure can be found in [S7 Data](#pbio.3000551.s018){ref-type="supplementary-material"} and [S8 Data](#pbio.3000551.s019){ref-type="supplementary-material"}. AIC, Akaike information criterion; NiDP, Noninteracting Distinct Pathogens.](pbio.3000551.g004){#pbio.3000551.g004}

Fitting the NiDP model allows us to test for interactions between *Plasmodium* spp., without assuming they are epidemiologically interchangeable. In 18 of the 41 cases we considered, our methods suggest the data are consistent with no interaction ([Fig 4B](#pbio.3000551.g004){ref-type="fig"}). We note that in 12 of these 18 cases, the methodology based on statistical independence of Howard and colleagues \[[@pbio.3000551.ref017]\] instead suggests the *Plasmodium* spp. interact.

Discussion {#sec011}
==========

We have shown that pathogens that do not interact and so have uncoupled prevalence dynamics ([Eq 1](#pbio.3000551.e001){ref-type="disp-formula"}) are not statistically independent. For two pathogens, the prevalence of coinfection is always greater than the product of the prevalences ([Eq 5](#pbio.3000551.e007){ref-type="disp-formula"}), unless host natural death does not occur. This result was first published in an age-structured, multistrain influenza model \[[@pbio.3000551.ref032]\]. Pathogens share a single host in coinfections, and so when a coinfected host dies, net prevalences of both pathogens decrease simultaneously. The prevalences of individual pathogens, regarded as random variables, therefore covary positively. A related interpretation is due to Kucharski and Gog \[[@pbio.3000551.ref032]\]: the prevalences of the pathogens are positively correlated through a single independent variable, namely the age of the hosts. As a side result, we note our analysis indicates that a high-profile, oft-cited model of May and Nowak \[[@pbio.3000551.ref055]\] is based on a faulty assumption of probabilistic independence ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 3). More importantly, our analysis also shows that statistically independent pathogens may well be interacting ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 5), which confirms that statistical independence is far from equivalent to the absence of biological interaction between pathogens.

More specifically, our results highlight that positive correlations between densities of infected hosts are a reasonable expectation, even if the pathogens in question do not interact. It might even be that a positive correlation is found when there is in fact a negative interaction, providing the confounding effect of age is sufficiently strong. In this context, results concerning the reliability of detecting associations between nematodes and intestinal coccidia (*Eimeria* spp.) in natural small-mammal populations presented by Fenton and colleagues \[[@pbio.3000551.ref014]\] are notable. These authors found that correlation-based cross-sectional analyses often revealed positive associations between pairs of parasites known to interact negatively with each other ([Fig 2](#pbio.3000551.g002){ref-type="fig"} in \[[@pbio.3000551.ref014]\]). Although our S-I-S model---strictly speaking---is not applicable to macroparasites, including nematodes, it might be that our results can provide a partial theoretical explanation of these findings (see also \[[@pbio.3000551.ref056]\], which reports a relative overabundance of positive associations between resident parasites of 22 small-mammal species). Testing whether and how our methods generalise to macroparasites would be an interesting development of the work presented here, and it is possible that such a modelling exercise would provide a theoretical context to understand these types of correlations in macroparasite data.

We extended our model to an arbitrary number of pathogens to develop a novel test for interaction that properly accounts for statistical nonindependence. Many data sets summarise coinfections in terms of multiplicity of infection, regardless of which pathogens are involved. Since there would then be as many epidemiological parameters as pathogens in our default NiDP model, and so as many parameters as data points, the full model would be overparameterised. We therefore introduced the additional assumption that all pathogens are epidemiologically interchangeable. This formed the basis of the parsimonious NiSP model, which is most appropriate for testing for interactions between strains or clones of a single pathogen species.

Despite the strong and perhaps even unrealistic assumption that strains/clones are interchangeable, the NiSP model outperformed the binomial model assuming statistical independence for all four data sets we considered. In particular, the NiSP model successfully captured the fat tails characteristic of observed multiplicity of infection distributions. All four data sets therefore support the idea that coinfection is far more frequent than statistical independence would imply.

For the data set concerning coinfection by different strains of HPV \[[@pbio.3000551.ref022]\], the NiSP model also passed a goodness of fit test, allowing us to conclude strains of this pathogen do not interact. Goodness of fit for such a simple model is a particularly conservative test, especially for the NiSP model, in which we assume pathogens clones/strains are epidemiologically interchangeable. However, our analysis relied on a model reflecting a natural history most suitable for chronic infections, with hosts infected until they die. In contrast, HPV infections may be acute, meaning there is clearance within a few years \[[@pbio.3000551.ref042]\]. However, extending our model to handle pathogen-specific rates of clearance ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 4) yielded qualitatively similar results ([S2 Text](#pbio.3000551.s002){ref-type="supplementary-material"}, Section 3; [S5 Fig](#pbio.3000551.s007){ref-type="supplementary-material"}), suggesting the difference in natural history between HPV and our model is not driving the results obtained here.

More generally, we wish to very explicitly highlight that here, we illustrated our methods via case studies for which suitable data are readily available, and our purpose was not to come to definitive conclusions concerning any particular system. That would require dedicated studies. However, by fitting even a highly simplified version of our model to data, we have demonstrated how results of simple epidemiological models challenge previous methods based on statistical independence.

To explore further the implications of our findings, we analysed available data sets, tracking distinct combinations of pathogens involved in each occurrence of coinfection. For methodological-comparison purposes, we restricted ourselves to data referenced by Howard and colleagues \[[@pbio.3000551.ref017]\] concerning interactions between *Plasmodium* spp. causing malaria. Relaxing the assumption of epidemiological interchangeability (i.e., using the NiDP model), we found that 43.9% (i.e., 18/41) of data sets considered by Howard and colleagues \[[@pbio.3000551.ref017]\] are consistent with no interaction.

One may wonder whether focusing on age classes may be sufficient to correct for the positive correlation between noninteracting pathogens \[[@pbio.3000551.ref031]\]. Of the 41 data sets identified by Howard and colleagues \[[@pbio.3000551.ref017]\] that we analysed, 14 focused only on data collected from children, and therefore, associations are less likely to emerge solely by the confounding effect of age \[[@pbio.3000551.ref035]\]. Of these 14 studies, we came to the same conclusion as Howard and colleagues \[[@pbio.3000551.ref017]\] in only six cases. We identified two cases in which our methods suggest there is an interaction in which Howard and colleagues \[[@pbio.3000551.ref017]\] concluded no interaction (studies 71 and 77), as well as six cases in which we conclude no interaction, whereas Howard and colleagues \[[@pbio.3000551.ref017]\] conclude there is an interaction (studies 76, 68, 69, 70, 79, and 80). Thus, focusing on discrete and arbitrary age classes may not be sufficient to correct for the positive correlation between noninteracting pathogens.

Again, we do not intend to conclusively demonstrate interactions---or lack of interactions---for malaria. Instead, what is important is that our results very often diverge from those originally reported by Howard and colleagues \[[@pbio.3000551.ref017]\] using a method based on statistical associations, namely log-linear regression. Log-linear regression suffers from well-acknowledged difficulties in cases in which there are zero counts (i.e., certain combinations of pathogens are not observed) \[[@pbio.3000551.ref057]\]. Such cases often arise in epidemiology. Methods based on epidemiological models therefore offer a 2-fold advantage: biological interactions are not confounded with statistical associations, and parameter estimation is well posed, irrespective of zero counts.

Moreover, simple epidemiological models (with no explicit age structure) intrinsically correct the bias due to the positive correlation between age and prevalence, which makes it unnecessary to control for age. Therefore (and this may be our main conclusion), although age is an evident confounding factor, epidemiological models make it unnecessary to keep track of the age of infected hosts. This is made possible by replacing the paradigm of 'statistical independence and random distributions' with 'model-based distributions in absence of biological interactions'.

We focused here on the simple S-I-S model, since it is sufficiently generic to be applicable to a number of systems. However, an important assumption of our model---as discussed earlier for the case of HPV---is that natural mortality occurs at a time scale comparable to that of an infection. Our model is therefore tailored for chronic (i.e., long-lasting) infections, although we note this represents a large fraction of coinfections in humans, animals, and (particularly) plants. Also, our study is restricted to nonlethal infections, as otherwise there may be ecological interactions between pathogens \[[@pbio.3000551.ref030]\]. In future work focusing on interactions between particular pathogens, models including additional system-specific detail would, of course, be appropriate.

Other work could also perhaps explicitly focus on more complex epidemiological dynamics that are relevant across an entire range of systems. As previously discussed, one possibility is of extending the work to include an underlying model that better represents macroparasite dynamics \[[@pbio.3000551.ref058]\]. Another example is simultaneous transmission of multiple pathogens/strains/clones, which can be particularly relevant in the case of chronic viruses \[[@pbio.3000551.ref059]\]. There are other aspects of host--pathogen interactions that can be important for the dynamics of chronic infections but that are omitted in the simple S-I-S type model. An obvious example is spatially explicit transmission rates, often represented in models by way of contact networks \[[@pbio.3000551.ref060]\] or individual-based models at small \[[@pbio.3000551.ref061]\] or large spatial scales \[[@pbio.3000551.ref062]\] or the meta-population paradigm \[[@pbio.3000551.ref063]\]. Another factor currently omitted is individual-level heterogeneity in transmission and/or susceptibility, for example, due to immunity \[[@pbio.3000551.ref064]\] or genetic variation within host populations \[[@pbio.3000551.ref065]\]. In principle, our methods could be extended by including these or any other heterogeneities in the underlying model and testing the extent to which such a model can explain observed prevalence data when pathogens are assumed not to interact. However, the difficulty would then be in model parameterisation, since it is unlikely that such complex models could straightforwardly be fitted using the type of cross-sectional data used here; but see Alizon and colleagues \[[@pbio.3000551.ref042]\] for parameter inference using Approximate Bayesian Computation in a model including host heterogeneity in behaviour. Consequently, we defer further analysis of these and other more complex underpinning epidemiological models to future research.

We also focused here on tests based on the equilibrium behaviour of our models. In practice, coinfecting pathogen populations might not yet have equilibrated within the host population of interest, and so it is possible that transient dynamics might play an important role. However, for tests to be used with cross-sectional data, the assumption of equilibrium is a logical point of departure. If longitudinal data were to be available, the methodology presented here could be extended in the obvious way, i.e., by explicitly fitting a compartmental model in which pathogens do not interact to prevalence data collected at multiple time points (see, e.g., \[[@pbio.3000551.ref040]\]). An initial investigation of the first time at which the prevalence of coinfection exceeds the product of prevalences in our simplest two-pathogen model suggests that it is often the case that the naïve prediction based on statistical independence becomes invalid relatively quickly, within the average lifetime of a single host. This remains the case for a wide variety of parameter sets and initial conditions ([S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 1.2; [S1 Fig](#pbio.3000551.s003){ref-type="supplementary-material"}). At least for our default parameter set (i.e., the parameters used in [Fig 2](#pbio.3000551.g002){ref-type="fig"}), irrespective of the initial condition, simulations of our stochastic model also indicate that any other transient behaviour is also 'washed out' of the system relatively quickly. The full relative deviation from statistical independence is therefore quickly attained irrespective of the particular initial conditions (see also [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 6.2; [S3 Fig](#pbio.3000551.s005){ref-type="supplementary-material"}). However, we defer more in-depth analysis of transient behaviour, including attempting to characterise when any signal might be detectable from real data, to future work.

Lastly, we speculate our results may have implications beyond epidemiology. After all, pathogens are species that form meta-populations occupying discrete patches (hosts) \[[@pbio.3000551.ref066]\]. Meta-community ecology has long been concerned with whether interactions between species can be detected from co-occurrence data \[[@pbio.3000551.ref043], [@pbio.3000551.ref067], [@pbio.3000551.ref068]\], and most existing methods are based on detecting statistical associations \[[@pbio.3000551.ref069], [@pbio.3000551.ref070]\] (but see also Hastings \[[@pbio.3000551.ref071]\]). We therefore simply highlight that our dynamical modelling approach may also provide a new perspective in this area.

Methods {#sec012}
=======

Mathematical analyses {#sec013}
---------------------

### Equilibria of the two-pathogen model {#sec014}

The two-pathogen model is given by Eqs [1](#pbio.3000551.e001){ref-type="disp-formula"}--[3](#pbio.3000551.e003){ref-type="disp-formula"}. Since the population size is constant, *J*~∅~ = 1−*J*~1~−*J*~2~−*J*~1,2~, and so it follows that $${\overset{˙}{J}}_{\varnothing} = \mu(J_{1} + J_{2} + J_{1,2}) - \left( {F_{1} + F_{2}} \right)J_{\varnothing} = \mu(1 - J_{\varnothing}) - \left( {F_{1} + F_{2}} \right)J_{\varnothing}.$$

It is well known \[[@pbio.3000551.ref052]\] that if *R*~0,*i*~ = *β*~*i*~/*μ*\>1 and *I*~*i*~(0)\>0, the prevalence of pathogen *i* will tend to an equilibrium ${\overline{I}}_{i} = 1 - 1/R_{0,i}$.

Since *F*~*i*~ = *β*~*i*~*I*~*i*~ and *J*~*i*~ = *I*~*i*~−*J*~1,2~, the rate of change of coinfected hosts in [Eq 3](#pbio.3000551.e003){ref-type="disp-formula"} can be recast as $${\overset{˙}{J}}_{1,2} = \beta_{2}I_{2}(I_{1} - J_{1,2}) + \beta_{1}I_{1}(I_{2} - J_{1,2}) - \mu J_{1,2},$$ which leads immediately to the results given in Eqs [4](#pbio.3000551.e005){ref-type="disp-formula"} and [5](#pbio.3000551.e007){ref-type="disp-formula"}.

### Equilibria of the *n*-pathogen model {#sec015}

The *n*-pathogen model is given by Eqs [1](#pbio.3000551.e001){ref-type="disp-formula"}, [6](#pbio.3000551.e008){ref-type="disp-formula"} and [7](#pbio.3000551.e009){ref-type="disp-formula"}. Since the host population size is constant, *J*~∅~ = 1−∑~Γ∈∇~*J*~Γ~, where ∇ is the set of all 2^*n*^−1 sets with infected or coinfected hosts. It is also true that $${\overset{˙}{J}}_{\varnothing} = \mu(1 - J_{\varnothing}) - \left( {\sum\limits_{i = 1}^{n}F_{i}} \right)J_{\varnothing}.$$

At equilibrium, [Eq 6](#pbio.3000551.e008){ref-type="disp-formula"} becomes $$0 = \sum\limits_{i \in \Gamma}{\overline{F}}_{i}{\overline{J}}_{\Omega_{i}} - \left( {\sum\limits_{i \notin \Gamma}{\overline{F}}_{i} + \mu} \right){\overline{J}}_{\Gamma},$$ in which ${\overline{J}}_{\Omega_{i}}$ and ${\overline{J}}_{\Gamma}$ are equilibrium prevalences, and ${\overline{F}}_{i}$ is the force of infection of pathogen *i* at equilibrium, i.e., $${\overline{F}}_{i} = \beta_{i}{\overline{I}}_{i} = \beta_{i}\left( {1 - \frac{\mu}{\beta_{i}}} \right) = \beta_{i} - \mu.$$

Since these forces of infection are constant and do not depend on the equilibrium prevalences, the set of 2^*n*^−1 equations partially characterising the equilibrium is linear, with $$0 = \sum\limits_{i \in \Gamma}\left( {\beta_{i} - \mu} \right){\overline{J}}_{\Omega_{i}} - \left( {\sum\limits_{i \notin \Gamma}\left( {\beta_{i} - \mu} \right) + \mu} \right){\overline{J}}_{\Gamma}.$$

Similarly, [Eq 10](#pbio.3000551.e014){ref-type="disp-formula"} is linear $$0 = \mu(1 - {\overline{J}}_{\varnothing}) - \left( {\sum\limits_{i = 1}^{n}(\beta_{i} - \mu)} \right){\overline{J}}_{\varnothing}.$$

The equilibrium prevalences can be written very conveniently in a recursive form (i.e., using the first equation to fix ${\overline{J}}_{\varnothing}$, using ${\overline{J}}_{\varnothing}$ to independently calculate all values of ${\overline{J}}_{\Gamma}$ for \|Γ\| = 1, then using the set of values of ${\overline{J}}_{\Gamma}$ when \|Γ\| = 1 to independently calculate all values of ${\overline{J}}_{\Gamma}$ for \|Γ\| = 2, and so on). A recurrence relation to find all equilibrium prevalences can therefore be initiated with the following expression for the density of uninfected hosts: $${\overline{J}}_{\varnothing} = \frac{\mu}{\mu + \sum\limits_{i = 1}^{n}(\beta_{i} - \mu)} = \frac{1}{1 + \sum\limits_{i = 1}^{n}(R_{0,i} - 1)}.$$

Then, one may recursively use the following equation, equivalent to [Eq 13](#pbio.3000551.e020){ref-type="disp-formula"}: $${\overline{J}}_{\Gamma} = \frac{\sum\limits_{i \in \Gamma}\left( {\beta_{i} - \mu} \right){\overline{J}}_{\Omega_{i}}}{\mu + \sum\limits_{i \notin \Gamma}\left( {\beta_{i} - \mu} \right)} = \frac{\sum\limits_{i \in \Gamma}\left( {R_{0,i} - 1} \right){\overline{J}}_{\Omega_{i}}}{1 + \sum\limits_{i \notin \Gamma}\left( {R_{0,i} - 1} \right)}.$$

Since the densities in [Eq 16](#pbio.3000551.e028){ref-type="disp-formula"} are entirely in terms of the equilibrium densities of hosts carrying one fewer pathogen (${\overline{J}}_{\Omega_{i}}$), this allows us to recursively find the densities of all pathogens given pathogen-by-pathogen values of *R*~0,*i*~.

### Deriving the NiSP model from the NiDP model {#sec016}

If all pathogens are interchangeable and so have identical values of *R*~0,*i*~ = *R*~0~ ∀~*i*~, then for any pair of combinations of infecting pathogens, Γ~1~ and Γ~2~, it must be the case that ${\overline{J}}_{\Gamma_{1}} = {\overline{J}}_{\Gamma_{2}}$ whenever \|Γ~1~\| = \|Γ~2~\|. This means the equilibrium prevalences of hosts infected by the same number of distinct pathogens must all be equal, irrespective of the particular combination of pathogens that is carried. In this case, solving the system is much simpler. First, [Eq 11](#pbio.3000551.e015){ref-type="disp-formula"} can be rewritten as $$\left. 0 = \middle| \Gamma \middle| \overline{F}{\overline{J}}_{\Omega_{i}} - \left( (n - \middle| \Gamma \middle| )\overline{F} + \mu \right){\overline{J}}_{\Gamma}, \right.$$ in which $\overline{F} = \beta - \mu$. The net prevalence of hosts infected by *k* distinct pathogens is $${\overline{M}}_{k} = \sum\limits_{\Gamma \in \nabla(k)}{\overline{J}}_{\Gamma},$$ in which ∇(*k*) is the set of combinations of {1,...,*n*} with *k* elements. Since the form of [Eq 17](#pbio.3000551.e031){ref-type="disp-formula"} depends only on \|Γ\|, all individual prevalences involved in ${\overline{M}}_{k}$ are identical, and so $${\overline{M}}_{k} = C_{k}^{n}{\overline{J}}_{\Gamma,k},$$ in which $C_{k}^{n}$ is a combinatorial coefficient, and ${\overline{J}}_{\Gamma,k}$ is any of the individual prevalences for which \|Γ\| = *k*. The ratio between successive values of ${\overline{M}}_{k}$ is given by $$\frac{{\overline{M}}_{k}}{{\overline{M}}_{k - 1}} = \frac{C_{k}^{n}}{C_{k - 1}^{n}}\frac{{\overline{J}}_{\Gamma,k}}{{\overline{J}}_{\Gamma,k - 1}} = \frac{n - k + 1}{k}\frac{{\overline{J}}_{\Gamma,k}}{{\overline{J}}_{\Gamma,k - 1}}.$$

From [Eq 15](#pbio.3000551.e027){ref-type="disp-formula"}, it follows that $${\overline{M}}_{0} = \frac{\mu}{\mu + n\overline{F}} = \frac{1}{1 + n(R_{0} - 1)},$$ in which *R*~0~ = *β*/*μ*. For 1≤*k*≤*n*, Eqs [17](#pbio.3000551.e031){ref-type="disp-formula"} and [20](#pbio.3000551.e039){ref-type="disp-formula"} together imply $${\overline{M}}_{k} = \frac{(n - k + 1)\overline{F}}{(n - k)\overline{F} + \mu}{\overline{M}}_{k - 1} = \frac{(n - k + 1)(R_{0} - 1)}{(n - k)(R_{0} - 1) + 1}{\overline{M}}_{k - 1},$$ a form that admits a simple recursive solution.

### Stochastic models {#sec017}

[Fig 2B and 2C](#pbio.3000551.g002){ref-type="fig"} were generated by simulating the stochastic differential equation (SDE) corresponding to [Eq 3](#pbio.3000551.e003){ref-type="disp-formula"}, simulating a continuous-time Markov chain model using Gillespie\'s algorithm gave consistent results. Confidence ellipses were obtained from an approximate expression for the covariance matrix at equilibrium (see below).

The continuous-time Markov chain model corresponding to the unscaled version of Eqs [3](#pbio.3000551.e003){ref-type="disp-formula"}--[8](#pbio.3000551.e011){ref-type="disp-formula"} tracks a vector of integer-valued random variables *X*(*t*) = (*J*~∅~(*t*),*J*~1~(*t*),*J*~2~(*t*),*J*~1,2~(*t*)). Defining Δ*X* = *X*(*t*+Δ*t*)−*X*(*t*) = (Δ*J*~∅~,Δ*J*~1~,Δ*J*~2~,Δ*J*~1,2~), changes of ±1 to each element of *X*(*t*) occur in small periods of time Δ*t* at the rates given in [Table 1](#pbio.3000551.t001){ref-type="table"}. Stochastic trajectories from this model can conveniently be simulated via the Gillespie algorithm \[[@pbio.3000551.ref072]\]. Note that the numeric values of the infection rates and the host birth rate must be altered to account for the scaling by population size.

10.1371/journal.pbio.3000551.t001

###### Transitions in the two-pathogen stochastic models.

The prevalence of uninfected host is *J*~∅~, the prevalence of each class of singly infected hosts is *J*~*i*~ (for *i*∈\[1,2\]), and the prevalence of coinfected host is *J*~1,2~. The net force of infection of pathogen *i* is *F*~*i*~ = *β*~*i*~*I*~*i*~/*N* = *β*~*i*~(*J*~*i*~+*J*~1,2~)/*N* (note the scaling by the population size *N* relative to the forces of infection as used in the deterministic version of the model). To ensure a constant host population size, we have made the simplifying assumption that removal and replacement occur simultaneously; this has no effect on our qualitative results.
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Event Number   Event                                                                                 Rate                         Change(s) to state variable(s) (Δ*X*)
  -------------- ------------------------------------------------------------------------------------- ---------------------------- ---------------------------------------
  1              Infection of uninfected host by pathogen 1                                            *F*~1~*J*~∅~Δ*t*+*o*(Δ*t*)   *J*~∅~→*J*~∅~−1\
                                                                                                                                    *J*~1~→*J*~1~+1

  2              Infection of uninfected host by pathogen 2                                            *F*~2~*J*~∅~Δ*t*+*o*(Δ*t*)   *J*~∅~→*J*~∅~−1\
                                                                                                                                    *J*~2~→*J*~2~+1

  3              Infection by pathogen 1 of host singly infected by pathogen 2                         *F*~1~*J*~2~Δ*t*+*o*(Δ*t*)   *J*~2~→*J*~2~−1\
                                                                                                                                    *J*~1,2~→*J*~1,2~+1

  4              Infection by pathogen 2 of host singly infected by pathogen 1                         *F*~2~*J*~1~Δ*t*+*o*(Δ*t*)   *J*~1~→*J*~1~−1\
                                                                                                                                    *J*~1,2~→*J*~1,2~+1

  5              Death of host singly infected by pathogen 1 and replacement with an uninfected host   *μJ*~1~Δ*t*+*o*(Δ*t*)        *J*~1~→*J*~1~−1\
                                                                                                                                    *J*~∅~→*J*~∅~+1

  6              Death of host singly infected by pathogen 2 and replacement with an uninfected host   *μJ*~2~Δ*t*+*o*(Δ*t*)        *J*~2~→*J*~2~−1\
                                                                                                                                    *J*~∅~→*J*~∅~+1

  7              Death of coinfected host and replacement with an uninfected host                      *μJ*~1,2~Δ*t*+*o*(Δ*t*)      *J*~1,2~→*J*~1,2~−1\
                                                                                                                                    *J*~∅~→*J*~∅~+1
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The model can also be written as a system of SDEs, an approximation to the continuous-time Markov chain that is valid for sufficiently large *N* \[[@pbio.3000551.ref073]\] and that is particularly well suited for simulation of the stochastic model when the population size is large. This form of the model again tracks the seven events in [Table 1](#pbio.3000551.t001){ref-type="table"}, although in the SDE formulation the random variables in *X*(*t*) are continuous-valued. A heuristic derivation is based on a normal approximation described below. Alternately, the forward Kolmogorov differential equations in the continuous-time Markov chain model are closely related to the Fokker-Planck equation for the probability density function of the SDE model \[[@pbio.3000551.ref074]\].

The expected change $\mathbb{E}(\Delta X)$ and covariance of the changes $\mathbb{V}(\Delta X)$ can be computed from [Table 1](#pbio.3000551.t001){ref-type="table"} to order Δ*t* via $$\mathbb{E}(\Delta X) \approx \widetilde{f}\Delta t\ {and}\ \mathbb{V}(\Delta X) \approx \mathbb{E}(\Delta X{\lbrack\Delta X\rbrack}^{T}) = \Sigma\Delta t,$$ where $dJ = \widetilde{f}dt$ is the unscaled version of the deterministic model as specified in Eqs [3](#pbio.3000551.e003){ref-type="disp-formula"}--[8](#pbio.3000551.e011){ref-type="disp-formula"} with *N* = *J*~∅~+*J*~1~+*J*~2~+*J*~1,2~ (a constant) and *F*~*i*~ = *β*~*i*~(*J*~*i*~+*J*~1,2~)/*N*. In addition, the matrix Σ is given by $$\begin{bmatrix}
{\mu(N - J_{\varnothing}) + (F_{1} + F_{2})J_{\varnothing}} & {- F_{1}J_{\varnothing} - \mu J_{1}} & {- F_{2}J_{\varnothing} - \mu J_{2}} & {- \mu J_{1,2}} \\
{- F_{1}J_{\varnothing} - \mu J_{1}} & {F_{1}J_{\varnothing} + (F_{2} + \mu)J_{1}} & 0 & {- F_{2}J_{1}} \\
{- F_{2}J_{\varnothing} - \mu J_{2}} & 0 & {F_{2}J_{\varnothing} + (F_{1} + \mu)J_{2}} & {- F_{1}J_{2}} \\
{- \mu J_{1,2}} & {- F_{2}J_{1}} & {- F_{1}J_{2}} & {F_{2}J_{1} + F_{1}J_{2} + \mu J_{1,2}} \\
\end{bmatrix}$$

The changes in a small time interval Δ*t* are approximated by a normal distribution via the central limit theorem: $\Delta X(t) - \mathbb{E}(\Delta X(t)) \approx {Normal}(0,\Sigma\Delta t)$, where 0 = zero vector. The covariance matrix Σ can be written as Σ = *GG*^*T*^. Letting Δ*t*→0, the SDE model can therefore be expressed as $$dX = \widetilde{f}dt + GdW.$$

The matrix *G* is not unique, but a simple form with dimension 4×7 accounts for each event in [Table 1](#pbio.3000551.t001){ref-type="table"} \[[@pbio.3000551.ref074]\]. Each entry in matrix *G* involves a square root, and *W* is a vector of seven independent standard Wiener processes, where d*W*~*i*~≈Δ*W*~*i*~(*t*) = *W*~*i*~(*t*+Δ*t*)−*W*~*i*~(*t*)\~Normal(0,Δ*t*). An explicit form for the SDE model in [Eq 25](#pbio.3000551.e048){ref-type="disp-formula"} is $$\begin{array}{l}
{dJ_{\varnothing} = {\widetilde{f}}_{0}dt - \sqrt{F_{1}J_{\varnothing}}dW_{1} - \sqrt{F_{2}J_{\varnothing}}dW_{2} + \sqrt{\mu J_{1}}dW_{5} + \sqrt{\mu J_{2}}dW_{6} + \sqrt{\mu J_{1,2}}dW_{7},} \\
{dJ_{1} = {\widetilde{f}}_{1}dt + \sqrt{F_{1}J_{\varnothing}}dW_{1} - \sqrt{F_{2}J_{1}}dW_{4} - \sqrt{\mu J_{1}}dW_{5},} \\
{dJ_{2} = {\widetilde{f}}_{2}dt + \sqrt{F_{2}J_{\varnothing}}dW_{2} - \sqrt{F_{1}J_{2}}dW_{3} - \sqrt{\mu J_{2}}dW_{6},} \\
{dJ_{1,2} = {\widetilde{f}}_{1,2}dt + \sqrt{F_{1}J_{2}}dW_{3} + \sqrt{F_{2}J_{1}}dW_{4} - \sqrt{\mu J_{1,2}}dW_{7}.} \\
\end{array}$$

In [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 2, we show that the covariance between the prevalences of pathogen 1 and pathogen 2 as they fluctuate in the vicinity of their equilibrium values is approximately $${cov}\left( {\frac{I_{1}}{N},\frac{I_{2}}{N}} \right) = \frac{\mu{\overline{J}}_{1,2}}{N^{2}\lbrack(\beta_{1} - \mu) + (\beta_{2} - \mu)\rbrack} = \frac{(\beta_{1} + \beta_{2})(\beta_{1} - \mu)(\beta_{2} - \mu)\mu}{N\beta_{1}\beta_{2}(\beta_{1} + \beta_{2} - \mu)(\beta_{1} - \mu + \beta_{2} - \mu)} \geq 0,$$ with equality if, and only if, *μ* = 0 (assuming *β*~*i*~\>*μ*, *i* = 1,2). Only in the specific case *μ* = 0 is the deviation from statistical independence equal to zero ([Eq 5](#pbio.3000551.e007){ref-type="disp-formula"}).

Statistical methods {#sec018}
-------------------

### Models corresponding to assuming statistical independence {#sec019}

If data are observations of numbers of individuals infected with *k* distinct pathogens, *O*~*k*~, for *k*∈\[0,*n*\], statistical independence corresponds to assuming the infection load of a single individual follows the one-parameter, binomial model Bin(*n*,*p*), in which *p* is the pathogen prevalence (assumed identical for each pathogen and fitted appropriately to the data), and *n* is the maximum number of infections that is possible (i.e., the total number of distinct pathogens under consideration). Model predictions are then simply *N* samples from this binomial distribution, where *N* = ∑~*k*~*O*~*k*~ is the total number of individuals observed in the data. One interpretation is as a multinomial model in which $$O_{k} \sim Nq_{k}\mspace{9mu}{where}\mspace{9mu} q_{k} = C_{k}^{n}p^{k}{(1 - p)}^{n - k}.$$

For the data for malaria corresponding to numbers of individuals, *O*~Γ~, infected by different sets of pathogens, Γ, statistical independence corresponds to an *n*-parameter multinomial model, parameterised by the prevalences of the individual pathogens *p*~*i*~ (again fitted to the data), i.e., $$O_{\Gamma} \sim N\prod\limits_{i \in \Gamma}p_{i}\prod\limits_{i \notin \Gamma}(1 - p_{i}).$$

### Fitting the models {#sec020}

The host natural death rate, *μ*, can be scaled out of the equilibrium prevalences by rescaling time. Fitting the models therefore corresponds to finding value(s) for scaled infection rate(s) *β*~*i*~, i.e., *R*~0,*i*~ = *β*~*i*~/*μ* (all are equal for the NiSP model).

The method used to fit the model does not depend on whether the data are numbers of hosts infected by a particular combination of pathogens or numbers of hosts carrying particular numbers of distinct pathogens, since both can be viewed as *N* samples drawn from a multinomial distribution, with *q*~*j*~ observations of the *j*^*th*^ class. If the corresponding probabilities generated by the model being fitted are *p*~*j*~, then the log-likelihood is $$L = \sum\limits_{j}q_{j}\log(p_{j}).$$

The models were fitted by maximising *L* via *optim()* in R \[[@pbio.3000551.ref075]\]. Convergence to a plausible global maximum was checked by repeatedly refitting the model from randomly chosen starting sets of parameters. All models were fitted in a transformed form to allow only biologically meaningful values of parameters; i.e., the basic reproduction numbers were estimated after transformation with log(*R*~0,*i*~−1) to ensure *R*~0,*i*~\>1.

### Model comparison {#sec021}

To compare the best-fitting NiSP or NiDP model and an appropriate model assuming statistical independence (binomial or multinomial), we use the Akaike information criterion $AIC = 2k - 2\hat{L}$, in which $\hat{L}$ is the log-likelihood of the best-fitting version of each model and *k* is the number of model parameters. This is necessary because these comparisons involve pairs of models that are not nested.

### Goodness of fit {#sec022}

We use a Monte-Carlo technique to estimate *p*-values for model goodness of fit, generating 1,000,000 independent sets of samples of total size *N* from the multinomial distribution corresponding to the best-fitting model, calculating the likelihood ([Eq 30](#pbio.3000551.e053){ref-type="disp-formula"}) of each of these synthetic data sets, and recording the proportion with a smaller value of *L* than the value calculated for the data \[[@pbio.3000551.ref076]\]. This was done using the function *xmonte*() in the R package *XNomial* \[[@pbio.3000551.ref077]\].

Sources of data and results of model fitting {#sec023}
--------------------------------------------

### Numbers of distinct pathogens (NiSP model) {#sec024}

Results of fitting the NiSP model to data from four publications for strains of a single pathogen are presented in [Fig 3](#pbio.3000551.g003){ref-type="fig"}. Error bars are 95% confidence intervals using exact methods for binomial proportions via *binconf()* in the R package *Hmisc* \[[@pbio.3000551.ref078]\]. Results for three further data sets concerning different pathogens of a single host \[[@pbio.3000551.ref046], [@pbio.3000551.ref048], [@pbio.3000551.ref050]\] are provided in Text S2 Section 1 (see also [S4 Fig](#pbio.3000551.s006){ref-type="supplementary-material"}).

For convenience, the raw data as extracted for use in model fitting are retabulated in [Table 2](#pbio.3000551.t002){ref-type="table"}. Results of model fitting are summarised in [Table 3](#pbio.3000551.t003){ref-type="table"}. We used the value *n* = 102 for the number of distinct strains by López-Villavicencio and colleagues \[[@pbio.3000551.ref045]\] following personal communication with the authors; there might be undetected genetic differences due to missing data---which would require a larger value of *n* in our model-fitting procedure---but we confirmed that our inferences are unaffected by taking any value of *n*∈\[100,200\].

10.1371/journal.pbio.3000551.t002

###### Sources of data for fitting the NiSP model in which pathogen types, clones, or strains are assumed to be epidemiologically interchangeable.

The data sets include human papillomavirus \[[@pbio.3000551.ref022]\], anther smut (*M*. *violaceum*) \[[@pbio.3000551.ref045]\], *B*. *afzelii* on bank voles \[[@pbio.3000551.ref046]\], and malaria (*P*. *vivax*) \[[@pbio.3000551.ref047]\]. The underlying data for this table can be found in [S1 Data](#pbio.3000551.s012){ref-type="supplementary-material"}.
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                                         Observed counts, *O*~*k*~   Total                                              
  -------------------------------- ----- --------------------------- ------- ----- ----- ----- ---- ---- ---- ---- ---- -------
  Human papillomavirus             25    2,933                       140     64    26    102   39   12   2    2    \-   5,412
  Anther smut (*M*. *violaceum*)   102   285                         74      60    32    14    3    3    2    1    1    475
  *B*. *afzelii* on bank voles     7     807                         33      26    13    10    11   6    \-   \-   \-   906
  Malaria (*P*. *vivax*)           57    1,023                       404     291   208   118   50   16   5    1    1    2,117

Abbreviation: NiSP, Noninteracting Similar Pathogens

10.1371/journal.pbio.3000551.t003

###### Fitting the NiSP model.

**The NiSP model was highly supported over the binomial model (Δ*AIC*≫10) in all cases tested.** The final column of the table corresponds to the GoF test of the NiSP model; the value *p*\>0.05 is highlighted in bold and corresponds to lack of evidence for failure to fit the data, and so the NiSP model is adequate for the data concerning human papillomavirus \[[@pbio.3000551.ref022]\].

![](pbio.3000551.t003){#pbio.3000551.t003g}

                                   NiSP    Binomial           GoF                
  -------------------------------- ------- ---------- ------- ---------- ------- -----------
  Human papillomavirus             1.032   −6,580.9   0.031   −6,868.8   575.8   **0.077**
  Anther smut (*M*. *violaceum*)   1.008   −614.0     0.008   −693.3     158.6   0.001
  *B*. *afzelii* on bank voles     1.044   −652.1     0.040   −799.0     293.8   0.000
  Malaria (*P*. *vivax*)           1.021   −3,169.2   0.021   −3,467.3   596.3   0.000

Abbreviations: AIC, Akaike information criterion; NiSP, Noninteracting Similar Pathogens; GoF, goodness of fit

### Combinations of pathogens (NiDP model) {#sec025}

Howard and colleagues \[[@pbio.3000551.ref017]\] report results of analysing 73 data sets concerning multiple *Plasmodium* spp. causing malaria (rows 68--140 of [Table 1](#pbio.3000551.t001){ref-type="table"} in that paper). We reanalysed the subset of these studies satisfying certain additional constraints as detailed in the main text (see [S2 Text](#pbio.3000551.s002){ref-type="supplementary-material"}, Section 2, for a full description of how the studies were filtered). This left a final total of 41 data sets taken from 35 distinct papers: 24 data sets considering the three-way interaction between *P*. *falciparum*, *P*. *malariae*, and *P*. *vivax* and 17 data sets considering the three-way interaction between *P*. *falciparum*, *P*. *malariae*, and *P*. *ovale*.

We used our method based on the NiDP model to test whether any of these data sets were consistent with no interaction between the *Plasmodium* spp. considered ([Table 4](#pbio.3000551.t004){ref-type="table"}). We found 15 data sets for which the NiDP model was (1) a better fit than the multinomial model as indicated by ΔAkaike information criterion (AIC) ≥ 2 and (2) sufficient to explain the data as revealed by our goodness of fit test. In these 15 cases, our methods therefore support the hypothesis of no interaction. For 11 of these 15 data sets (76, 109, 118, 130, 132, 68, 69, 70, 79, 95, 97, 98, 99, 100, 102), the results as reported by Howard and colleagues \[[@pbio.3000551.ref017]\] instead suggest the strains interact.

10.1371/journal.pbio.3000551.t004

###### Fitting the NiDP model.

Data sets that are consistent with no interaction between the *Plasmodium* spp. considered are highlighted in grey (and have a row number marked with bold font in the first column). Such data sets have both *p*-values for the GoF test of the NiDP model *p*(GoF)\>0.05 (marked in bold in the sixth column), and Δ*AIC*≥2 (for the comparison between the NiDP model and the multinomial model; marked in bold in the 12th column), meaning the NiDP model is adequate. The multinomial model corresponds to the statistical independence hypothesis. Parameters *R*~0,1~ and *R*~0,2~ are associated with *P*. *falciparum* and *P*. *malariae*, respectively. Parameter *R*~0,3~ corresponds either to *P*. *vivax* (upper part of the table, data sets 74--137) or to *P*. *ovale* (lower part of the table, data sets 68--103). The final column contains a "Y" whenever at least one association between a pair of pathogens was assessed to be significant by Howard and colleagues \[[@pbio.3000551.ref017]\] (and "N" when not significant). A "Y" in cells shaded pink correspond to possible statistical associations that are consistent with our no-interaction model (NiDP), i.e., cases in which our methods lead to results diverging from those reported in \[[@pbio.3000551.ref017]\].
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  Row number in [Table 1](#pbio.3000551.t001){ref-type="table"} in \[[@pbio.3000551.ref017]\]   NiDP     Multinomial           Association(s) in \[[@pbio.3000551.ref017]\]                                                                       
  --------------------------------------------------------------------------------------------- -------- ------------- ------- ---------------------------------------------- ----------- ------- ------- ------- ----------- ------- ----------- ---
  74                                                                                            1.764    1.256         1.004   −340.7                                         0.000       0.468   0.220   0.004   −311.0      0.000   −59.3       Y
  75                                                                                            1.694    1.248         1.022   −194.8                                         0.000       0.445   0.215   0.022   −177.4      0.000   −34.8       Y
  **76**                                                                                        1.235    1.019         1.005   −492.5                                         **0.251**   0.190   0.019   0.005   −493.7      0.098   **2.4**     Y
  82                                                                                            1.776    1.165         1.108   −996.0                                         0.000       0.463   0.147   0.101   −936.3      0.000   −119.2      Y
  84                                                                                            1.212    1.017         1.207   −684.2                                         0.000       0.180   0.017   0.177   −660.4      0.000   −47.6       Y
  88                                                                                            1.296    1.120         1.260   −314.7                                         0.000       0.242   0.111   0.217   −295.0      0.000   −39.3       Y
  106                                                                                           1.818    1.146         1.055   −4,105.2                                       0.000       0.442   0.125   0.052   −4,296.6    0.000   382.9       Y
  108                                                                                           1.241    1.024         1.096   −1,147.5                                       0.000       0.197   0.023   0.089   −1,132.1    0.721   −30.9       N
  **109**                                                                                       1.023    1.013         1.045   −359.3                                         **0.866**   0.023   0.013   0.043   −361.1      0.343   **3.5**     Y
  111                                                                                           1.198    1.005         1.786   −1,929.2                                       0.000       0.175   0.005   0.467   −1,798.8    0.000   −260.7      Y
  **112**                                                                                       1.307    1.086         1.056   −119.6                                         **0.115**   0.241   0.080   0.054   −116.6      0.552   −6.0        N
  113                                                                                           1.213    1.007         1.119   −1,324.1                                       0.000       0.179   0.007   0.108   −1,290.8    0.000   −66.6       Y
  114                                                                                           1.615    1.084         1.038   −1,224.4                                       0.000       0.392   0.080   0.037   −1,182.6    0.000   −83.6       Y
  116                                                                                           1.780    1.124         1.100   −1,035.1                                       0.000       0.471   0.116   0.094   −953.5      0.000   −163.2      Y
  117                                                                                           1.072    1.000         1.268   −31,530.5                                      0.000       0.068   0.000   0.214   −30,958.7   0.000   −1,143.5    Y
  **118**                                                                                       1.085    1.039         1.171   −225.3                                         **0.990**   0.078   0.037   0.146   −227.5      0.515   **4.5**     Y
  119                                                                                           1.433    1.164         1.375   −265.7                                         0.000       0.325   0.146   0.291   −249.0      0.146   −33.6       Y
  123                                                                                           1.016    1.055         1.098   −6,684.7                                       0.000       0.016   0.052   0.090   −6,623.5    0.000   −122.4      Y
  124                                                                                           1.254    1.100         1.082   −3,600.6                                       0.000       0.206   0.092   0.076   −3,541.3    0.017   −118.7      Y
  127                                                                                           1.341    1.005         1.266   −1,087.4                                       0.000       0.265   0.005   0.219   −1,039.0    0.000   −96.8       Y
  **130**                                                                                       1.013    1.002         1.350   −352.7                                         **0.978**   0.013   0.002   0.259   −353.7      0.636   **2.0**     N
  **132**                                                                                       1.397    1.027         1.074   −591.8                                         **0.347**   0.285   0.026   0.068   −594.3      0.067   **4.9**     Y
  133                                                                                           1.571    1.022         1.332   −687.9                                         0.000       0.375   0.022   0.257   −676.2      0.001   −23.4       Y
  137                                                                                           1.196    1.005         1.130   −2,356.8                                       0.000       0.166   0.005   0.117   −2,309.6    0.000   −94.3       Y
  **68**                                                                                        1.910    1.091         1.021   −152.0                                         **0.200**   0.469   0.082   0.020   −157.8      0.002   **11.7**    Y
  **69**                                                                                        4.827    1.443         1.036   −177.2                                         **0.822**   0.796   0.310   0.035   −181.4      0.121   **8.5**     Y
  **70**                                                                                        4.612    1.203         1.089   −239.2                                         **0.953**   0.781   0.168   0.082   −247.4      0.012   **16.4**    Y
  71                                                                                            6.070    1.370         1.181   −310.1                                         0.001       0.822   0.261   0.148   −336.2      0.000   52.1        N
  77                                                                                            14.275   1.383         1.142   −155.3                                         0.032       0.944   0.286   0.127   −150.4      0.931   −9.9        N
  **78**                                                                                        4.171    1.178         1.006   −166.2                                         **0.264**   0.773   0.153   0.006   −163.2      0.997   −5.8        N
  **79**                                                                                        1.855    1.033         1.005   −1,260.1                                       **0.969**   0.461   0.032   0.005   −1,263.4    0.224   **6.6**     Y
  **80**                                                                                        1.546    1.062         1.021   −715.1                                         **0.735**   0.355   0.059   0.020   −715.2      0.675   0.2         Y
  **95**                                                                                        1.855    1.033         1.005   −1,260.1                                       **0.970**   0.461   0.032   0.005   −1,263.4    0.224   **6.6**     N
  96                                                                                            1.910    1.071         1.017   −240.4                                         0.019       0.469   0.065   0.016   −248.9      0.000   17.1        N
  **97**                                                                                        1.952    1.077         1.004   −242.6                                         **0.568**   0.486   0.071   0.004   −246.7      0.031   **8.3**     Y
  **98**                                                                                        1.662    1.014         1.018   −183.7                                         **0.373**   0.396   0.013   0.018   −187.0      0.030   **6.6**     N
  **99**                                                                                        1.627    1.019         1.019   −133.7                                         **0.823**   0.384   0.019   0.019   −135.6      0.332   **3.8**     N
  **100**                                                                                       1.037    1.003         1.000   −432.1                                         **0.254**   0.035   0.003   0.000   −433.2      0.083   **2.3**     Y
  101                                                                                           3.590    1.269         1.063   −11,014.1                                      0.000       0.720   0.211   0.060   −11,392.7   0.000   757.3       Y
  **102**                                                                                       2.473    1.153         1.027   −8,188.9                                       **0.403**   0.595   0.132   0.027   −8,352.0    0.000   **326.2**   Y
  103                                                                                           1.798    1.180         1.015   −7,425.7                                       0.000       0.437   0.150   0.015   −7,736.6    0.000   621.8       Y

Abbreviations: AIC, Akaike information criterion; GoF, goodness of fit; NiDP, Noninteracting Distinct Pathogens

Code availability {#sec026}
-----------------

Code illustrating all statistical methods is freely available at <https://github.com/nikcunniffe/Coinfection>.

Supporting information {#sec027}
======================

###### Mathematical supplements.

Further mathematical details on the models considered in the main text, as well as showing how the models can be extended to account for pathogen-specific rates of clearance.

(PDF)

###### 

Click here for additional data file.

###### Sources of data and side results of model fitting.

Gives more details on how data was selected and extracted, as well as discussing additional results of fitting the models that are not presented in the main text.

(PDF)

###### 

Click here for additional data file.

###### Numerical investigation of the switching time in the deterministic two-pathogen model.

Panels (A) and (C) show how the switching time was calculated for both 'random' (A) and 'one pathogen is invading' (C) initial conditions (described in [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"} Section 1.2) with epidemiological parameters chosen via a randomisation procedure (which ensured *R*~0,1~ and *R*~0,2~ were independently uniformly distributed between 1 and 5). The distribution of switching times over a large number of replicates (B and D) show the switching time is always less than the mean lifetime of an individual host for both initial condition scenarios. In both cases, any transient is therefore likely to have only limited impact (see also [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"} Section 6).

(TIF)

###### 

Click here for additional data file.

###### Impact of environmental stochasticity on the deviation between the density of coinfecteds and product of the prevalences in a stochastic two-pathogen model.

The stochastic differential equation version of the two-pathogen model was simulated 10^3^ times, in a population *N* = 1,000, but the individual epidemiological parameters *β*~1~, *β*~2~, and *μ* were allowed to vary according to the Cox-Ingersoll-Ross process in Eq S77 in [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"} (with mean values following the parameterisation used in [Fig 2](#pbio.3000551.g002){ref-type="fig"} of the main text). The three rows show results for *σ* = 0 (i.e., no environmental noise), *σ* = 0.25 (i.e., intermediate environmental noise), and *σ* = 0.5 (i.e., relatively high environmental noise). (A, E, and I) The evolution of the parameters over time in an individual replicate simulation. (B, F, and J) The corresponding trajectories for the density of infected hosts. (C, G, and K) The distribution of 10^3^ point estimates of (*I*~1~,*I*~2~) when *T* = 10. (D, H, and L) The empirical distribution of the relative deviation from statistical independence $\Lambda = ({\overline{J}}_{1,2} - \overline{P})/\overline{P}$ over the 10^3^ simulations at each level of noise. For all three levels of noise, the full distributions of Λ remain reliably above zero. (Note that since the level of noise is set to zero for the results shown in the top row, panels B, C, and D essentially replicate [Fig 2B, 2C and 2D](#pbio.3000551.g002){ref-type="fig"} in the main text).

(TIFF)

###### 

Click here for additional data file.

###### Impact of transient behaviour on the deviation between the density of coinfecteds and product of the prevalences.

The stochastic differential equation version of the two-pathogen model with the parameterisation used in [Fig 2](#pbio.3000551.g002){ref-type="fig"} of the main text was simulated 1,000 times with random initial conditions, in a population *N* = 1,000. The 95% interval on the value of Λ as extracted from individual simulations at different times is shown for different assumptions on the initial conditions (see also [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"}, Section 1.2). (A) Random initial conditions, with densities of all four state variables chosen at random. (B) One pathogen is invading the other, which is initially at equilibrium.

(TIF)

###### 

Click here for additional data file.

###### Comparing the best-fitting NiSP model with a binomial model (i.e., statistical independence) for data sets in which different pathogens are considered.

Model-fitting results are shown for (A) pathogens of *Ixodes ricinus* ticks \[[@pbio.3000551.ref050]\], (B) barley and cereal yellow dwarf viruses \[[@pbio.3000551.ref049]\], and (C) human respiratory viruses \[[@pbio.3000551.ref048]\]. Insets to each panel show a 'zoomed-in' section of the graph corresponding to high multiplicities of pathogen coinfection, using a logarithmic scale on the y-axis for clarity. Asterisks indicate predicted counts smaller than 0.1. For the data shown in (A), there is no evidence that the NiSP model does not fit the data, and so our test indicates the pathogens do not interact. For the data shown in (B), although the NiSP model is a better fit to the data than the binomial model, there is evidence of lack of goodness of fit, and so our test indicates these pathogens interact (or are epidemiologically different). For the data shown in (C), although the binomial model is a better fit to the data than the NiSP model, there is evidence of lack of goodness of fit, and again it can be concluded that these pathogens interact (or are epidemiologically different). The underlying data for this figure can be found in [S9 Data](#pbio.3000551.s020){ref-type="supplementary-material"}, [S10 Data](#pbio.3000551.s021){ref-type="supplementary-material"}, and [S11 Data](#pbio.3000551.s022){ref-type="supplementary-material"}. NiSP, Noninteracting Similar Pathogens.

(TIF)

###### 

Click here for additional data file.

###### Comparing the best-fitting two-parameter NiSP model with a binomial model (i.e., statistical independence).

Model-fitting results are shown for human respiratory viruses \[[@pbio.3000551.ref048]\]. The inset shows a 'zoomed-in' section of the graph corresponding to high multiplicities of pathogen coinfection, using a logarithmic scale on the y-axis for clarity. The best-fitting NiSP model converges to the binomial model in this case (which is a special case of NiSP for *μ* = 0, see [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"} \[Section 4\]). The underlying data for this figure can be found in [S12 Data](#pbio.3000551.s023){ref-type="supplementary-material"}. NiSP, Noninteracting Similar Pathogens.

(TIF)

###### 

Click here for additional data file.

###### Sources of data for fitting the NiSP model in which pathogen species, clones, or strains are assumed to be epidemiologically interchangeable, even though different pathogens are considered.

The data sets include pathogens of *I*. *ricinus* ticks \[[@pbio.3000551.ref050]\], barley yellow dwarf viruses \[[@pbio.3000551.ref049]\], and respiratory viruses \[[@pbio.3000551.ref048]\]. The underlying data for this table can be found in [S1 Data](#pbio.3000551.s012){ref-type="supplementary-material"}. NiSP, Noninteracting Similar Pathogens.

(PDF)

###### 

Click here for additional data file.

###### Additional examples of fitting the NiSP model.

The NiSP model was highly supported over the binomial model (Δ*AIC*≫10) in all cases tested but one (respiratory viruses), in which the binomial model is highly supported over the NiSP model. The final column of the table corresponds to the GoF test of the NiSP model; values *p*\>0.05 correspond to lack of evidence for failure to fit the data, and so the NiSP model is adequate for the data concerning pathogens of *I*. *ricinus* ticks \[[@pbio.3000551.ref050]\]. AIC, Akaike information criterion; GoF, goodness of fit; NiSP, Noninteracting Similar Pathogens.

(PDF)

###### 

Click here for additional data file.

###### Data sets as extracted from the source references for studies focusing on interactions between *P*. *falciparum*, *P*. *malariae*, and either *P*. *vivax* (i.e., 'FMV') or *P*. *ovale* (i.e., 'FMO').

The asterisks indicate that the corresponding data sets were extracted from the large compendium collated in 1930 by Knowles and White. The number in the leftmost column shows the number of the relevant row in [Table 1](#pbio.3000551.t001){ref-type="table"} of \[[@pbio.3000551.ref017]\]. The rows with (!) correspond to studies for which the total number of individuals sampled as reported by \[[@pbio.3000551.ref017]\] do not match what we found on interrogating the original paper; in all cases, we used the corrected values as shown in the table. The notation 'X' (in FX, MX, or FMX) corresponds either to 'V' (i.e., *P*. *vivax*, upper part of the table, data sets 74--137) or to 'O' (i.e., *P*. *ovale*, lower part of the table, data sets 68--103). The underlying data for this table can be found in [S2 Data](#pbio.3000551.s013){ref-type="supplementary-material"}.

(PDF)

###### 

Click here for additional data file.

###### Fitting the NiSP model to data sets corresponding to human papillomavirus \[[@pbio.3000551.ref022]\], pathogens of *I*. *ricinus* ticks \[[@pbio.3000551.ref050]\], anther smut (*M*. *violaceum*) \[[@pbio.3000551.ref045]\], barley yellow dwarf viruses \[[@pbio.3000551.ref049]\], *B*. *afzelii* on bank voles \[[@pbio.3000551.ref046]\], malaria (*P*. *vivax*) \[[@pbio.3000551.ref047]\], and human respiratory viruses \[[@pbio.3000551.ref048]\].

Parameters for the best-fitting variant of the NiSP model for each pathogen species, strain, or clone are highlighted in bold; the two-parameter model is supported in cases for which *p*\<0.05 in the 'Model Selection' part of the table (including human papillomavirus and malaria \[*P*. *vivax*\]). The NiSP model was highly supported over the binomial model (Δ*AIC*≫10) in all cases tested but one (human respiratory viruses). The final column of the table corresponds to the GoF test of the best-fitting model; values *p*\>0.05 correspond to lack of evidence for failure to fit the data, and so the NiSP model is adequate for the data concerning human papillomavirus and pathogens of *I*. *ricinus* ticks. These results are qualitatively identical to those for the model without specific clearance as presented in the main text. Note that in the NiSP model, *β* and *γ* are scaled relative to *μ*. This is why *β* and *γ* of NiDP reach extremely high values for respiratory viruses. Parameter estimation tends to *μ* = 0, which actually corresponds to the binomial model, which has one fewer parameter (see [S1 Text](#pbio.3000551.s001){ref-type="supplementary-material"} Section 4.5 and [S5 Fig](#pbio.3000551.s007){ref-type="supplementary-material"}). Hence, Δ*AIC* = −2 for respiratory viruses, since the NiSP model requires one additional parameter compared to the binomial model. AIC, Akaike information criterion; GoF, goodness of fit; NiDP, Noninteracting Distinct Pathogens; NiSP, Noninteracting Similar Pathogens.

(PDF)

###### 

Click here for additional data file.

###### Data underlying [Table 2](#pbio.3000551.t002){ref-type="table"} and [S1 Table](#pbio.3000551.s008){ref-type="supplementary-material"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [S3 Table](#pbio.3000551.s010){ref-type="supplementary-material"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [Fig 3A](#pbio.3000551.g003){ref-type="fig"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [Fig 3B](#pbio.3000551.g003){ref-type="fig"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [Fig 3C](#pbio.3000551.g003){ref-type="fig"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [Fig 3D](#pbio.3000551.g003){ref-type="fig"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [Fig 4A](#pbio.3000551.g004){ref-type="fig"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [Fig 4B](#pbio.3000551.g004){ref-type="fig"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [S4A Fig](#pbio.3000551.s006){ref-type="supplementary-material"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [S4B Fig](#pbio.3000551.s006){ref-type="supplementary-material"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [S4C Fig](#pbio.3000551.s006){ref-type="supplementary-material"}.

(CSV)

###### 

Click here for additional data file.

###### Data underlying [S5A Fig](#pbio.3000551.s007){ref-type="supplementary-material"}.

(CSV)

###### 

Click here for additional data file.
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Your revisions should address the specific points made by each reviewer. Please submit a file detailing your responses to the editorial requests and a point-by-point response to all of the reviewers\' comments that indicates the changes you have made to the manuscript. In addition to a clean copy of the manuscript, please upload a \'track-changes\' version of your manuscript that specifies the edits made. This should be uploaded as a \"Related\" file type. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

Before you revise your manuscript, please review the following PLOS policy and formatting requirements checklist PDF: <http://journals.plos.org/plosbiology/s/file?id=9411/plos-biology-formatting-checklist.pdf>. It is helpful if you format your revision according to our requirements - should your paper subsequently be accepted, this will save time at the acceptance stage.

Please note that as a condition of publication PLOS\' data policy (<http://journals.plos.org/plosbiology/s/data-availability>) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: <http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5>.

For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article\'s figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: <https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements>.

Upon resubmission, the editors assess your revision and assuming the editors and Academic Editor feel that the revised manuscript remains appropriate for the journal, we may send the manuscript for re-review. We aim to consult the same Academic Editor and reviewers for revised manuscripts but may consult others if needed.

We expect to receive your revised manuscript within one month. Please email us (<plosbiology@plos.org>) to discuss this if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not wish to submit a revision and instead wish to pursue publication elsewhere, so that we may end consideration of the manuscript at PLOS Biology.

When you are ready to submit a revised version of your manuscript, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' where you will find your submission record.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don\'t hesitate to contact us if you have any questions or comments.

Sincerely,

Di Jiang, PhD

Associate Editor

on behalf of

Lauren A Richardson, Ph.D

Senior Editor

PLOS Biology

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer remarks:

Reviewer \#1: This manuscript tackles an issue of growing recognition - how to infer the presence of interspecific parasite interactions from cross-sectional data. This is a problem since, particularly for wildlife systems, longitudinal or experimental data are rare, so we often have to rely on data of this form to draw conclusions of how and to what extent co-infecting parasites interact with each other. This ms very neatly demonstrates that the fundamental assumption that non-interacting parasites should show statistical independence in their co-occurrence is wrong, due to the likely positive correlations that arise due to the confounding effect of host age. The authors then show how this non statistical independence can be accounted for, nicely illustrated with re-fitting models to previously published data.

Overall this is a very well written, elegant and informative ms, and I think it very clearly makes important points about some of our fundamental assumptions about our null models regarding patterns of co-association between non-interacting species. I only have a couple of very minor additional suggestions:

\- Equation 4 is presented as the measure of deviation of the prevalence of co-infection from that of statistical independence, and how this is affected by host longevity - that\'s fine, but I found Equation 9 (in the Methods) to be a much nicer/clearer representation, clearly showing that if mu=0 (essentially immortal hosts) then the observed co-infection prevalence equals the expected proportion assuming independence - whereas as mu increases (mean host lifespan decreases) this difference accentuates. I wonder if Eq 9 can be brought into the main text to help reinforce these points.

\- Line 153 states the \"deviation \[between co-infection prevalence and that required by statistical independence\] is zero if an only if the host natural death rate = 0\". Yes, that\'s strictly true, but (from Eqns 4/9\] it would also be approximately true if the R0 and/or transmission rates of either or both pathogens are large - the deviation tends to zero as beta1 and/or beta2 increase. Biologically this means we would expect to see the assumption of statistical independence violated for pathogens with high transmission rates/R0s, whereas those with very low transmission rates (assuming R0 remains \> 1) we would likely not see much departure from the assumption of statistical independence. It might be useful to make this point explicitly here.

\- I found it very interesting that this ms highlights the expectation of positive correlations among parasites, even if they don\'t interact (or presumably even if they negatively interact, providing the confounding age effect is sufficiently strong) - as this matches the finding in Fenton et al 2014 IJP that most correlation-based cross-sectional analyses revealed positive associations between pairs of parasites that are known to interact negatively with each other (their Fig 2). I wonder if it\'s useful to make this point in the Discussion somewhere, as a theoretical explanation for this empirically-observed result.

Reviewer \#2: This paper uses SIS models to show why systems of non-interacting pathogens will---counter to intuition---always appear to exhibit statistical dependence according to conventional metrics, simply on account of positive correlations between I1 and I2 that are generated when coinfected hosts die. The authors go on to develop some statistical tests based on this insight that can account for this effect, and they re-analyze a number of datasets with the new tests. The problem is tackled quite thoroughly by the authors, who present several lines of methodological evidence along with numerical simulations and empirical analyses. I think this paper will be of broad interest to the infectious disease modelling community, and even more broadly in population biology and epidemiology. The paper is also very well-written and the figures are clear. I only have a few minor revisions to suggest:

1\. The analysis relies heavily on the SIS natural history which is suitable for chronic infections (as the authors point out). However, they apply their test to HPV, which exhibits short-lived natural immunity followed by clearance, in most cases. In the Discussion section, the authors should discuss in more detail how other natural histories would influence their findings, including their finding of independence for HPV strains. I assume it would make their findings conservative.

2\. The proof in S1.1 only shows that Z becomes negative after a finite time t1, meaning that it could be positive before that. Hence, depending on how large t1 is, we could observe either J1,2 \> I1\*I2 or vice versa. Please comment and explain whether this is a significant limitation, and adjust writing in main text as needed.

3\. Following on comment \#2, the authors could either expand their numerical analysis depicted in Figure 2 to explore whether transient dynamics have any interesting impact on the relationship between J1,2 and I1\*I2. Alternatively, they could include some speculation about the impact of transients in the Discussion section.

Reviewer \#3: It was a pleasure to read the manuscript by Hamelin et al. touching on the important question in ecology and epidemiology whether co-infections of non-interacting pathogens are statistically independent. Building upon prior work by Kucharski et al., the manuscript showcases a wide range of tools from ODE and SDE modelling to statistics. It provides a practical tool to test for interactions between pathogens based on cross-sectional data for chronic infectious diseases explicitly accounting for non-independence of co-infection prevalences. The availability of source code and data gathered from previous studies will further benefit the research community.

Major comments

In the SDE model, especially Figure 2B, the authors show only a single replicate to underpin non-independence, i.e. that the product prevalence is lower the the co-infection prevalence. It would be interesting to see a more representative number of replicates (with mean and confidence interval bands). Would then the product prevalence still be statistically significantly different from the the co-infection prevalence?

Concerning the positive correlation between pathogen prevalences resulting from the covariance matrix of fluctuations near the equilibrium, the authors mentioned the works of O'Dea et al. (2018). In the cited paper, assumptions on environmental (multiplicative gamma white) noise play an import role in the calculation of the covariance matrix. Would you expect that the absence of biological interactions between pathogens (as seen in the HPV example) would still be identifiable with your approach if your model was augmented by such environmental factors?

Similarly, in your discussion section you touch upon whether structural model constraints (e.g. age classes) should necessarily be accounted for in order to test for non-interaction between pathogens. It would be interesting to sketch strategies how to deal with structures (e.g. networks, meta-populations, immunity) that are relevant for chronic diseases and that might mask interactions.

Minor comments

Main text

line 343 replace "of of" by "of"

Supplementary materials

S.1.4.3

In equation (S37) the first term on the right-hand side lacks a minus sign. The same holds for the following equalities, the first terms lack a minus sign.

S.1.4.4

It is not clear whether this paragraph concerns the case of negligible mortality, as μ does not appear in equation (S38). On the other hand, you refer later in line 241 to the specific case of μ=0.

10.1371/journal.pbio.3000551.r003
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Senior Editor
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Lauren A Richardson

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

18 Oct 2019

Dear Dr Cunniffe,

Thank you for submitting your revised Research Article entitled \"Co-infections by non-interacting pathogens are not independent and require new tests of interaction\" for publication in PLOS Biology.

The Academic Editor and I have now assessed your revision, and we are delighted to let you know that we are essentially satisfied and will not require re-review. We do ask that you 1) explicitly mention the focus on chronic infections in the abstract and 2) on l290 (\'we note our analysis indicates a high-profile model of May and Nowak\'), clarify what \'high-profile\' means here (e.g. \'commonly used\' or \'oft-cited\'). We will publish your study, assuming you are willing to make these final edits and those needed to meet our production requirements. Congratulations!

Before we can formally accept your paper and consider it \"in press\", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can\'t proceed until these requirements are met, your swift response will help prevent delays to publication.

Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

To submit your revision, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' to find your submission record. Your revised submission must include a cover letter, a Response to Reviewers file that provides a detailed response to the reviewers\' comments (if applicable), and a track-changes file indicating any changes that you have made to the manuscript.

Please do not hesitate to contact me should you have any questions.

Sincerely,

Lauren A Richardson, Ph.D

Senior Editor

PLOS Biology

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: <http://journals.plos.org/plosbiology/s/data-availability>. For more information, please also see this editorial: <http://dx.doi.org/10.1371/journal.pbio.1001797>

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1\) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as \'Supporting Information\' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2\) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels: (e.g. Figs. 3A-D, 4AB, S4A-C, S5), as they are essential for readers to assess your analysis and to reproduce it.

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found and includes a list of all the data sources.
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4 Nov 2019

Dear Dr Cunniffe,

On behalf of my colleagues and the Academic Editor, Adam J Kucharski, I am pleased to inform you that we will be delighted to publish your Research Article in PLOS Biology.

The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you\'ll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication.

Early Version

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <biologypress@plos.org>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <http://www.plos.org/about/media-inquiries/embargo-policy/>.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.

Kind regards,

Sofia Vickers

Senior Publications Assistant

PLOS Biology

On behalf of,

Lauren Richardson,

Senior Editor

PLOS Biology

[^1]: The authors have declared that no competing interests exist.
